In this week's Research Ethics Roundup, we explore some of the ethical and practical questions posed by new innovations in the research enterprise, as well as some age old concerns, such as the recruitment of subjects for clinical trials. Read on:
FDA, Sponsors Look to Expand Patient Input to Clinical Trials: The involvement of patient groups in the design of clinical trials is becoming increasingly common. In this article for Applied Clinical Trials, Jill Wechsler reports on this shift, as well as the Food and Drug Administration's efforts to foster patient-focused drug development.
by Joan Rachlin, JD, MPH, Executive Director
Last week, Lawrence Altman, MD, The New York Times’ senior statesman of science writing, published a piece titled “Of Medical Giants, Accolades and Feet of Clay.” The article focused on [...] Read more
Do April showers have you stuck indoors? Take a moment to peruse the latest installment of our Research Ethics Roundup. This week’s issue features articles on a wide range of topics, including how history should remember researchers with checkered pasts, why science tends to favor positive results, and much more.
Building public trust in genomic research: In this response to Read more
by Karen M. Meagher, PhD, senior policy and research analyst at the Presidential Commission for the Study of Bioethical Issues
The Presidential Commission for the Study of Bioethical Issues (PCSBI) has consistently noted the marked need for effective ethics education. With this commitment in mind, the Commission recently released a companion study guide to its 2011 historical investigation report, <[...] Read more
In this week’s Research Ethics Roundup, the 3Rs, bias in research, and compensation for research participants serve as food for thought.
What does the increase in numbers of animals used in research mean?: Statistics indicating that the use of animals in scientific research in the United Kingdom (UK) increased in 2011 were recently released. While some are concerned that this trend may indicate deviation from the 3Rs –reduction, refinement, and replacement– others believe the implications of these statistics may be more benign.